Clinical importance of transforming growth factor-β but not of tumor necrosis factor-α gene polymorphisms in patients with the myelodysplastic syndrome belonging to the refractory anemia subtype

Pathobiology

Volumn 72, Issue 3, 2005, Pages 165-170

  Balog, Attila ^a   Borbényi, Zita ^a   Gyulai, Zsófia ^a   Molnár, Lenke ^b   Mándi, Yvette ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Gene polymorphisms; Myelodysplastic syndrome; Refractory anemia; Transforming growth factor ; Tumor necrosis factor

Indexed keywords

TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REFRACTORY ANEMIA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ANEMIA, REFRACTORY; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS); TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 18744416837     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084121     Document Type: Article

References (32)

1. Hellström-Lindberg E, Willman C, Barrett AJ, Saunthararajah Y: Achievements in understanding and treatment of myelodysplastic syndromes. Hematology (Am Soc Hematol Educ Program) 2000, pp 110-132.
2. Greenberg PL, Young NS, Gattermann N: Myelodysplastic syndromes. Hematology (Am Soc Hematol Educ Program) 2002, pp 136-161.
3. Moldoveanu E, Moicean A, Vidulescu C, Marta D, Colita A: Apoptotic rate in patients with myelodysplastic syndrome treated with modulatory compounds of pro-apoptotic cytokines. J Cell Mol Med 2003;7:313-321.
4. Kiss C, Benko I, Kovacs P: Leukemic cells and the cytokine patchwork. Pediatr Blood Cancer 2004;42:113-121.
5. Blobe GC, Schiemann WP, Lodish HF: Role of transforming growth factor beta in human disease. N Engl J Med 2000;342:1350-1358.
6. Bruno E, Horrigan SK, Van Den Berg D, Rozler E, Fitting PR, Moss ST, Westbrook C, Hoffman R: The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis. Blood 1998;91:1917-1923.
7. Allampallam K, Shetty V, Mundle S, Dutt D, Kravitz H, Reddy PL, Alvi S, Galili N, Saberwal GS, Anthwal S, Shaikh MW, York A, Raza A: Biological significance of proliferation, apoptosis, cytokines, and monocyte/macrophage cells in bone marrow biopsies of 145 patients with myelodysplastic syndrome. Int J Hematol 2002;75:289-297.
8. Maciejewski JP, Risitano AM, Sloand EM, Wisch L, Geller N, Barrett JA, Young NS, Ristiano AM: A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndrome. Br J Haematol 2002;117:119-126.
9. Greenberg P: Treatment of myelodysplastic syndrome with agents interfering with inhibitory cytokines. Ann Rheum Dis 2001;60(suppl 3):iii41-iii42.
10. Hofmann WK, Seipelt G, Ottmann OG, Kalina U, Koschmieder S, Brucher J, Frickhofen N, Klausmann M, Mitrou PS, Hoelzer D: Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels. Ann Hematol 2000;79:255-258.
11. Wilson AG, di Giovine FS, Blakemore AI, Duff GW: Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992;1:353.
12. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-3199.
13. Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SG, Pena AS: Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 1996;43:456-463.
14. Wood NA, Thomson SC, Smith RM, Bidwell JL: Identification of human TGF-beta1 signal (leader) sequence polymorphisms by PCR-RFLP. J Immunol Methods 2000;234:117-122.
15. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV: Genotypic variation in the transforming growth factor-beta1 gene: Association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998;66:1014-1020.
16. Arkwright PD, Laurie S, Super M, Pravica V, Schwarz MJ, Webb AK, Hutchinson IV: TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax 2000;55:459-462.
17. Hinke V, Seck T, Clanget C, Scheidt-Nave C, Ziegler R, Pfeilschifter J: Association of transforming growth factor-beta1 (TGFbeta1) T29→C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-beta1 in a population-based sample of postmenopausal German women. Calcif Tissue Int 2001;69:315-320.
18. Turner D, Grant SC, Yonan N, Sheldon S, Dyer PA, Sinnott PJ, Hutchinson IV: Cytokine gene polymorphism and heart transplant rejection. Transplantation 1997;64:776-779.
19. Azzawi M, Hasleton PS, Turner DM, Yonan N, Deiraniya AK, Sinnott PJ, Hutchinson IV: Tumor necrosis factor-alpha gene polymorphism and death due to acute cellular rejection in a subgroup of heart transplant recipients. Hum Immunol 2001;62:140-142.
20. Bathgate AJ, Pravica V, Perrey C, Therapondos G, Plevris JN, Hayes PC, Hutchinson IV: The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation 2000;69:1514-1517.
21. Nadel S, Newport MJ, Booy R, Levin M: Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 1996;174:878-880.
22. Tang GJ, Huang SL, Yien HW, Chen WS, Chi CW, Wu CW, Lui WY, Chiu JH, Lee TY: Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 2000;28:2733-2736.
23. Warle MC, Farhan A, Metselaar HJ, Hop WC, Perrey C, Zondervan PE, Kap M, de Rave S, Kwekkeboom J, Ijzermans JN, Tilanus HW, Pravica V, Hutchinson IV, Bouma GJ: Cytokine gene polymorphisms and acute human liver graft rejection. Liver Transpl 2002;8:603-611.
24. Xaubet A, Marin-Arguedas A, Lario S, Ancochea J, Morell F, Ruiz-Manzano J, Rodriguez-Becerra E, Rodriguez-Arias JM, Inigo P, Sanz S, Campistol JM, Mullol J, Picado C: Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003;168:431-435.
25. Holweg CT, Baan CC, Niesters HG, Vantrimpont PJ, Mulder PG, Maat AP, Weimar W, Balk AH: TGF-beta1 gene polymorphisms in patients with end-stage heart failure. J Heart Lung Transplant 2001;20:979-984.
26. Clancy RM, Backer CB, Yin X, Kapur RP, Molad Y, Buyon JP: Cytokine polymorphisms and histologic expression in autopsy studies: Contribution of TNF-alpha and TGF-beta1 to the pathogenesis of autoimmune-associated congenital heart block. J Immunol 2003;171:3253-3261.
27. Rosenfeld C, List A: A hypothesis for the pathogenesis of myelodysplastic syndromes: Implications for new therapies. Leukemia 2000;14:2-8.
28. Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV: ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphisms. Transpl Immunol 1999;7:127-128.
29. Gersuk GM, Beckham C, Loken MR, Kiener P, Anderson JE, Farrand A, Troutt AB, Ledbetter JA, Deeg HJ: A role for tumour necrosis factor-alpha, Fas and Fas-ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol 1998;103:176-188.
30. Gowans D, O'Sullivan A, Rollinson S, Roddam P, Groves M, Fegan C, Morgan G, Bowen D: Allele and haplotype frequency at human leucocyte antigen class I/II and immunomodulatory cytokine loci in patients with myelodysplasia and acute myeloid leukaemia: In search of an autoimmune aetiology. Br J Haematol 2002;117:541-545.
31. Stoll C, Mengsteab S, Stoll D, Riediger D, Gressner AM, Weiskirchen R: Analysis of polymorphic TGFBI codons 10, 25, and 263 in a German patient group with non-syndromic cleft lip, alveolus, and palate compared with healthy adults. BMC Med Genet 2004;5:15.
32. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y: Association of a T29→C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000;101:2783-2787.